Comments
Loading...
Addex Therapeutics (NASDAQ:ADXN) Stock, Earnings Estimates, EPS, And Revenue
Addex Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Sep 30
EPS
$10.610
Quarterly Revenue
$127.2K
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$829.9K
Analyze the earnings history of Addex Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Addex Therapeutics (ADXN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2021 | 2021-11-04 | $-14.40 | $-14.40 | 0.00 % |
| Jun 2021 | 2021-08-05 | $-18.00 | $-13.00 | -38.5 % |
Addex Therapeutics (ADXN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-09-30 | $127.15K | $ | -51.1 % |
| Sep 2023 | 2023-11-29 | $370.87K | $700.00K | -47.0 % |
| Sep 2021 | 2021-11-04 | $825.37K | $420.00K | 96.5 % |
| Jun 2021 | 2021-08-05 | $1.18M | $260.00K | 452307600.0 % |
FAQ
When is Addex Therapeutics (NASDAQ:ADXN) reporting earnings?
Addex Therapeutics (ADXN) is scheduled to report earnings on November 22, 2024. The last reported earnings were for reported on September 30, 2024 for Q2.
What were the latest earnings per share (EPS) for Addex Therapeutics (NASDAQ:ADXN)?
The Actual EPS was $10.61, which beat the estimate of $0.00.
What were Addex Therapeutics’s (NASDAQ:ADXN) revenues?
The Actual Revenue was $127.2K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.